Skip to main content
SpringerLink
Log in

A controlled trial of nebulized salbutamol and adrenaline in acute severe asthma

  • Original
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Objective

To compare efficacy and safety of nebulisation of adrenaline (2 mg over 10 min) and salbutamol (5 mg over 10 min) in acute severe asthma.

Design

Prospective randomized and double blind study.

Setting

Intensive care unit of a University teaching hospital.

Patients and participants

22 asthmatic patients presenting to the emergency room with acute severe asthma.

Interventions

Patients were randomly assigned to receive either adrenaline (n=11) or salbutamol (n=11) via a nebulizer. Additional treatment comprised hydrocortisone hemisuccinate (100 mg) and supplemental oxygen (7l/min). The efficacy and safety of both drugs were evaluated at 20 and 40 min.

Results

A statistically significant increase in the Peak Expiratory Flow (PEF) was achieved at the 20th min in both groups (from 85±38 l/min to 120±45 l/min;p<0.001; and from 107±28 l/min to 145±19 l/min;p<0.001; in adrenaline group and salbutamol group respectively). With both drugs, PEF further increased at 40 min to a level that was statistically significant when compared to the 20 min evaluation. The magnitude of the absolute variation in PEF was similar with both drugs. Both drugs induced a significant decrease in heart rate, respiratory frequency and PaCO2 while the increase of PaO2/FIO2 ratio was not significant. The decrease of respiratory frequency at 40 min was more important with salbutamol (p=0.03). No side effects were recorded in both groups.

Conclusion

After a single dose, nebulized adrenaline (2 mg) proved as effective and safe as salbutamol (5 mg) in acute severe asthma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Clark TJH (1983) Acute severe asthma. In: Clark TJH, Godfrey S (eds) Asthma, 2nd edn. Chapman and Hall, London, pp 414–422

    Google Scholar 

  2. Crompton GK (1990) Nebulized or intravenous β2 adreno-receptor agonist therapy in acute asthma (Editorial). Eur Respir J 3:125–126

    PubMed  CAS  Google Scholar 

  3. Swedish Society of Chest Medicine (1990) High-dose inhaled versus intravenous salbutamol combined with theophylline in severe acute asthma. Eur Respir J 3:163–170

    Google Scholar 

  4. Salmeron S, Brenot F, Duroux P (1988) Bases pharmacologiques de l'utilisation des β agonistes au cours de l'etat de mal asthmatique. J EUR 1:47–53

    Google Scholar 

  5. Salmeron S, Brochard L, Mal H, Tenaillon A, Henry-Amar M, Renon D, (1989) Intravenous of inhaled salbutamol in status asthmaticus. A multicenter double blind study. Chest 96 [Suppl]:1365

    Google Scholar 

  6. Solis-Cohen S (1900) The use of adrenal substance in the treatment of asthma. J Am Med Assoc 34:1164–1266

    Google Scholar 

  7. Olsson O, Ekdah A (1985) The use of two different pharmacological principles to inhibit a cholinergic bronchospasm in Guinea pig. Acta Pharmacol Toxicol 56:316–320

    Article  CAS  Google Scholar 

  8. Anderson RGG, Fugnera Lundgren BR (1986) Inhibitory effects of clonidine on bronchospasm induced in Guinea pigs by vagal stimulation or antigen challenge. Eur J Pharmacol 123: 181–185

    Article  Google Scholar 

  9. Salmeron S, Parrot A, Phlippoteau C, Brenot F, Petitpretz P, Simmoneau G (1990) Nebulized adrenaline after non response to β2 agonists in severe acute asthma (abstract). Am Rev Respir Dis 141:A398

    Google Scholar 

  10. Robert R, Dore P, Malin F, Meurice JC, Gombert J, Patte D (1992) Efficacité et tolérance des aérosols d'adrenaline dans l'asthme aigu grave. Réanim Urgence 1:707–711

    Article  Google Scholar 

  11. Coupe MO, Guly V, Bronw E, Barnes PJ (1987) Nebulized adrenaline in acute severe asthma: comparison with salbutamol. Eur J Respir Dis 71: 227–232

    PubMed  CAS  Google Scholar 

  12. ATS Guidelines (1987) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136:225–244

    Google Scholar 

  13. Editorial (1992) Reversibility of airflow obstruction: FEV 1 vs peak flow Lancet 340:85–86

  14. Harf A (1992) How to express the reversibility of bronchial obstruction? Eur Respir J 5:919–920

    PubMed  CAS  Google Scholar 

  15. Tattersfield AE (1986) Clinical applications of beta agonists. In: Kay AB (ed) Asthma: Clinical pharmacology and therapeutic progress. Blackwell, Oxford, pp 161–170

    Google Scholar 

  16. Dulfano MJ, Glass P (1976) The bronchodilator effects of terbutaline: route of administration and patterns of response. Amn Allergy 37:357–366

    CAS  Google Scholar 

  17. Ahrens RC, Bonham C, Maxwell GA (1984) A method for comparing the peak intensity and duration of aerosolized bronchodilators using bronchoprovocation with metacholine, Am Rev Respir Dis 129:903–906

    PubMed  CAS  Google Scholar 

  18. Baker DG, Basbaum CB, Herbert DA (1983) Transmission in airway ganglia of ferrets: inhibition by norepinephrine. Neurosci Lett 41:139–143

    Article  PubMed  CAS  Google Scholar 

  19. Grundstrom N, Andersson RGG, Wikberg JES (1981) Prejunctional alpha 2-adrenaline receptors inhibit contraction of tracheal smooth muscle by inhibiting cholinergic transmission. Life Sci 28:2981–2986

    Article  PubMed  CAS  Google Scholar 

  20. Warren JB, Doble N, Dalton N (1985) Systemic absorption of inhaled adrenaline. Clin Sci 69:49

    Google Scholar 

  21. Dulfano MJ, Glass P (1976) The bronchodilator effects of terbutaline: route of administration and patterns of response. An Allergy 37:357–366

    CAS  Google Scholar 

  22. Schwartz HS, Trantlein JJ, Goldstein AR (1976) Acute effects of terbutaline and epinephrine in asthma. J Allergy Clin Immunol 58:516–522

    Article  PubMed  CAS  Google Scholar 

  23. Barnes PJ (1986) Neural control of human airways in health and disease. Am Rev Respir Dis 134:1289–1314

    PubMed  CAS  Google Scholar 

  24. Knudson RJ, Constantine HP (1967) An effect of isoproterenol on ventilation-perfusion in asthmatic versus normal subjects. J Appl Physiol 22:402–486

    PubMed  CAS  Google Scholar 

  25. Harris L (1972) Comparison of the effects on blood gases, ventilation and perfusion of isoproterenol-phenylephrine and salbutamol in chronic bronchitis with asthma. J Allergy Clin Immunol 49:63–71

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de Réanimation Polyvalente, CHU Fattouma Bourguiba, 5019, Monastir, Tunisia

    F. Abroug, S. Nouira, A. Bchir, R. Boujdaria, S. Elatrous & S. Bouchoucha

Authors
  1. F. Abroug
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Nouira
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Bchir
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Boujdaria
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Elatrous
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Bouchoucha
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abroug, F., Nouira, S., Bchir, A. et al. A controlled trial of nebulized salbutamol and adrenaline in acute severe asthma. Intensive Care Med 21, 18–23 (1995). https://doi.org/10.1007/BF02425149

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02425149

Key words

Search

Navigation